Small molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts.

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Bone Tissue Engineering

Background:

• Human pluripotent stem cells (hPSCs) offer potential for regenerative medicine due to their self-renewal and differentiation capabilities.
• Efficiently converting hPSCs into specific cell types, like osteoblasts, remains a significant challenge for therapeutic applications.
• Existing methods for osteogenic differentiation can be complex and costly, hindering clinical translation.

Purpose of the Study:

• To investigate the direct conversion of hPSCs into functional osteoblasts using adenosine.
• To elucidate the mechanism of adenosine-mediated osteogenesis, including the role of adenosine receptors.
• To evaluate the in vivo bone regeneration capacity of adenosine-differentiated hPSCs.

Main Methods:

• Treatment of hPSCs with adenosine to induce osteogenic differentiation.
• Analysis of osteoblast molecular signatures and matrix production.
• In vivo implantation of differentiated cells in macroporous synthetic matrices to assess bone defect repair.
• Histological and functional evaluation of newly formed bone tissue.

Main Results:

• Adenosine treatment successfully induced hPSCs to express osteoblast markers and produce calcified bone matrix.
• Adenosine-mediated osteogenesis was found to involve the adenosine A2b receptor.
• Implanted hiPSC-derived cells promoted the repair of critical-sized bone defects, forming vascularized neobone tissue without teratoma formation.
• The regenerated bone exhibited characteristics of native bone, including vascularization and resorption.

Conclusions:

• Adenosine is a potent, physiologically relevant small molecule capable of directly inducing hPSC differentiation into functional osteoblasts.
• Adenosine-mediated osteogenesis provides a simple, cost-effective, and scalable method for generating osteoprogenitor cells from hPSCs.
• This approach holds significant promise for advancing cell manufacturing and translational applications in bone regenerative medicine.